The European Commission welcomes the historic political agreement on the Critical Medicines Act (CMA) reached by the Council and the European Parliament. This agreement marks a significant milestone in strengthening the resilience of the European healthcare sector, preventing medicine shortages and improving the security of supply of essential medicines across the EU. The CMA will […]
Internships – EMA training programmes – Netherlands
The European Medicines Agency offers internships for university graduates at its headquarters in Amsterdam, the Netherlands. The aim is for interns to gain an understanding of how the Agency operates and its role within the EU. The programme runs from 1 October to 31 July each year. Requirements: Recent university graduates (up to 12 months […]
Parliament calls for the EU to continue taking action to combat cancer
Need for a specific EU health programme in the next long-term EU budget Improving access to treatment for cancer patients across Europe Reducing financial discrimination for cancer survivors In 2024, 2.7 million people were diagnosed with cancer in the EU and 1.27 million died from the disease. MEPs want the EU to renew its political […]
EU measures to tackle shortages of essential medicines
Investment to boost production capacity in Europe and increase autonomy “Buy European” to support production Promoting joint public procurement between Member States Drug shortages are often due to production difficulties The regulation will cover antibiotics, insulin, vaccines and medicines for chronic diseases Parliament adopted proposals to improve the availability and supply of essential medicines in […]
Critical medicines act: Council agrees its position on new rules to tackle shortages
The Council has agreed its position on a new regulation that seeks to strengthen the EU’s resilience in the face of ongoing challenges to security of supply of critical medicines in Europe. The critical medicines act (CMA) aims to tackle shortages in key medicines such as antibiotics, insulin and painkillers by improving security of supply and availability in the […]
Propose new regulations to ensure a supply of essential medicines.
Patients in the EU should have access to the medicines they need, when they need them. Unfortunately, in recent years EU countries have been confronted with severe medicine shortages, made worse by global events such as the COVID-19 pandemic. The Critical Medicines Act, proposed by the Commission today, aims to support manufacturing and improve the availability […]
European Commission steps up action to tackle critical shortages of medicines and strengthen security of supply in the EU
The Commission has adopted a set of actions to better prevent and mitigate critical medicine shortages in the EU, this winter, next winter and beyond. Recent critical shortages, including of certain antibiotics last winter, show that continued coordinated action is needed to address supply challenges and to make Europe’s medicine supply chains more resilient in […]
European Commission proposes overhaul of EU pharmaceuticals legislation
The Commission proposes to revise the EU’s pharmaceutical legislation – the largest reform in over 20 years – to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more available, accessible and affordable. It will support innovation and boost the competitiveness and attractiveness of the EU pharmaceutical […]
EU ensures continued supply of medicines to Northern Ireland, Cyprus, Ireland and Malta
The European Commission welcomes the swift adoption by the Council of the proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta – markets that have been historically supplied through or by Great Britain. This adoption follows last week’s […]